M87.188
Osteonecrosis due to drugs, other site
Clinical Classification Guidelines
Medical Intelligence & Overview
Osteonecrosis due to drugs, classified under ICD-10 code M87.188, is a condition where bone tissue dies as a result of improper blood supply, primarily caused by adverse effects of certain medications. This condition can affect various parts of the body, leading to pain, joint dysfunction, and bone collapse if left untreated. It's a rare but serious complication associated with specific drug therapies, demanding awareness to ensure early detection and management.
Causes & Symptoms
Clinical Causes: Long-term use of corticosteroids, such as prednisone High-dose corticosteroid therapy for medical conditions like autoimmune diseases or after organ transplantation The use of bisphosphonates, particularly when administered intravenously for osteoporosis or cancer-related bone metastases Exposure to other medications that impair blood flow to bones, including certain chemotherapeutic agents Combination treatments involving multiple medications that may synergistically increase risk
Key Symptoms: Dull or aching pain in the affected area, which may worsen with activity Limited range of motion in nearby joints Swelling and tenderness over the affected bone or joint Progressive joint stiffness or instability Bone collapse or secondary deformities in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment and imaging studies. Physicians may recommend the following:
Treatment Protocols: Managing osteonecrosis due to drugs primarily aims to relieve symptoms, halt progression, and preserve joint function. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is M87.188 a billable ICD-10 code?
Yes, M87.188 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M87.188?
Clinical documentation must specify the nature of Osteonecrosis due to drugs, other site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference